ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

DNAX DNA Brands Inc (PK)

0.0004
-0.0001 (-20.00%)
01 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
DNA Brands Inc (PK) USOTC:DNAX OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.0001 -20.00% 0.0004 0.0003 0.0005 0.0004 0.00035 0.0004 5,330,000 21:00:01

1-z/a: Amendment to Exit Report Under Regulation a (1-z/a)

09/03/2021 9:01pm

Edgar (US Regulatory)


Form 1-Z Issuer Information


FORM 1-Z

UNITED STATE
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 1-Z
EXIT REPORT UNDER REGULATION A

OMB APPROVAL

OMB Number: ####-####

Estimated average burden hours per response: ##.#

1-Z: Filer Information

Issuer CIK
0001419995
Issuer CCC
XXXXXXXX
File Number
24R-00357
Is this filing by a successor company pursuant to Rule 257(b)(5) resulting from a merger or other business combination?
o Yes x No
Successor File Number
Is this a LIVE or TEST Filing?
x LIVE o TEST
Is this an electronic copy of an official filing submitted in paper format?
o
Would you like a Return Copy?
o

Submission Contact Information

Name
Phone
E-Mail Address
Notify via Filing Website only?
o

1-Z: PRELIMINARY INFORMATION

Exact name of issuer as specified in the issuer's charter
DNA Brands Inc
Address of Principal Executive Offices
Address 1
275 E. Commercial Blvd., #208
Address 2
City
Lauderdale by the Sea
State/Country
FLORIDA
Mailing Zip/ Postal Code
33308
Phone
561-654-5722
Commission File Number(s)
024-11053

1-Z: PART I Summary Information Regarding the Offering and Proceeds

Summary Information

Date of qualification of the offering statement
01-17-2020
Date of commencement of the offering
01-17-2020
Amount of securities qualified to be sold in the offering
2500000000
Amount of securities sold in the offering
337812500
Price per security:
$ 0.0008
The portion of aggregate sales attributable to securities sold on behalf of the issuer
$ 270000.00
The portion of aggregate sales attributable to securities sold on behalf of selling securityholders:
$ 0.00

Fees in connection with this offering and names of service providers.

Underwriters - Name of Service Provider
Underwriters - Fees
$
Sales Commissions - Name of Service Provider
Sales Commissions - Fee
$
Finders' Fees - Name of Service Provider
Finders' Fees - Fees
$
Audit - Name of Service Provider
Audit - Fees
$
Legal - Name of Service Provider
Milan Saha
Legal - Fees
$ 20000.00
Promoters - Name of Service Provider
Shore Thing Media LLC
Promoters - Fees
$ 70000.00
Blue Sky Compliance - Name of Service Provider
NY & CO
Blue Sky Compliance - Fees
$ 2500.00
CRD Number of any broker or dealer listed
Net proceeds to the issuer
$ 227500.00
Clarification of responses (if necessary):

1-Z: PART II Certification of Suspension of Duty to File Reports

Certification

Title of each class of securities covered by this Form
Common Stock
Commission File Number(s)
024-11053
Approximate number of holders of record as of the certification date
400

1-Z: Signature

Signature

Pursuant to the requirements of Regulation A,

Cik
0001419995
(Name of issuer as specified in charter)
DNA BRANDS INC

certifies that it meets all of the conditions for termination of Regulation A reporting specified in Rule 257(d) and that there are no classes of securities other than those that are the subject to this Form 1-Z regarding which the issuer has Regulation A reporting obligations.

(Name of issuer as specified in charter)
DNA BRANDS INC

Has caused this certification to be signed on its behalf by the undersigned duly authorized person.

By
Adrian McKenzie-Patasar
Date
03-09-2021
Title
CEO

Instructions: This Part II of Form 1-Z is required by Rule 257(d) of Regulation A. An officer of the issuer or any other duly authorized person may sign, and must do so by typed signature. The name and title of the person signing the form must be typed or printed under the signature. The signatory to the filing must also manually sign a signature page or other document authenticating, acknowledging or otherwise adopting his or her signature that appears in the filing. Such document must be executed before or at the time the filing is made and must be retained by the issuer for a period of five years. Upon request, the issuer must furnish to the Commission or its staff a copy of any or all documents retained

1 Year DNA Brands (PK) Chart

1 Year DNA Brands (PK) Chart

1 Month DNA Brands (PK) Chart

1 Month DNA Brands (PK) Chart

Your Recent History

Delayed Upgrade Clock